Malignant Eye Neoplasm — Trials

Malignant Eye Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

446 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 83
Recruiting: 44
Ph III recruiting: 10
Growth YoY: —
Industry share: 30%
Top sponsor: IDEAYA Biosciences
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (67)

clinicaltrialsPublishedShowing 101–150 of 213 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01551459	A Phase II Study of Sunitinib Versus Dacarbazine in the Treatment of Patients With Metastatic Uveal Melanoma(SUAVE)	completed	Phase 2	124	The Clatterbridge Cancer Centre NHS Foundation TrustOTHER	1	Oct 29, 2019	clinicaltrials
NCT00690469	Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers	completed	—	234	Children's Oncology GroupNETWORK